Universal Beteiligungs und Servicegesellschaft mbH Buys 6,396 Shares of Stryker Corporation $SYK

Universal Beteiligungs und Servicegesellschaft mbH raised its position in Stryker Corporation (NYSE:SYK) by 1.5% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 429,220 shares of the medical technology company’s stock after purchasing an additional 6,396 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Stryker were worth $158,670,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in SYK. Mid American Wealth Advisory Group Inc. bought a new position in shares of Stryker during the 2nd quarter valued at approximately $26,000. Clayton Financial Group LLC purchased a new position in shares of Stryker during the 3rd quarter valued at $26,000. Elevation Point Wealth Partners LLC purchased a new position in shares of Stryker during the 2nd quarter valued at $28,000. Sachetta LLC grew its stake in shares of Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares during the period. Finally, Kilter Group LLC purchased a new stake in Stryker in the 2nd quarter worth about $29,000. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CAO William E. Berry, Jr. sold 1,953 shares of the stock in a transaction on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the transaction, the chief accounting officer owned 2,833 shares of the company’s stock, valued at $1,035,433.17. This represents a 40.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Ronda E. Stryker sold 276,173 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the sale, the director directly owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. This represents a 9.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 522,118 shares of company stock valued at $185,381,932 in the last quarter. Corporate insiders own 5.20% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on SYK. Wells Fargo & Company upped their price objective on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a report on Friday, November 14th. Needham & Company LLC restated a “buy” rating and set a $448.00 price target on shares of Stryker in a research note on Friday, November 14th. Evercore ISI set a $390.00 price objective on shares of Stryker in a research note on Monday, January 5th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Finally, Truist Financial lowered their price target on shares of Stryker from $400.00 to $392.00 and set a “hold” rating on the stock in a report on Thursday, December 18th. Fourteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $430.00.

Stryker Price Performance

Stryker stock opened at $359.59 on Wednesday. The stock has a market cap of $137.52 billion, a price-to-earnings ratio of 47.25, a PEG ratio of 2.33 and a beta of 0.89. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68. The business has a 50-day simple moving average of $360.31 and a 200 day simple moving average of $373.37. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The firm had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. During the same quarter last year, the company posted $2.87 EPS. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be paid a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. This is a boost from Stryker’s previous quarterly dividend of $0.84. Stryker’s dividend payout ratio is presently 46.25%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.